KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Depreciation & Amortization (CF) (2017 - 2025)

Historic Depreciation & Amortization (CF) for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $176.0 million.

  • Elanco Animal Health's Depreciation & Amortization (CF) rose 352.94% to $176.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $670.0 million, marking a year-over-year increase of 14.95%. This contributed to the annual value of $662.0 million for FY2024, which is 461.1% down from last year.
  • Per Elanco Animal Health's latest filing, its Depreciation & Amortization (CF) stood at $176.0 million for Q3 2025, which was up 352.94% from $169.0 million recorded in Q2 2025.
  • Elanco Animal Health's 5-year Depreciation & Amortization (CF) high stood at $202.0 million for Q1 2021, and its period low was $161.0 million during Q1 2025.
  • For the 5-year period, Elanco Animal Health's Depreciation & Amortization (CF) averaged around $171.6 million, with its median value being $170.0 million (2021).
  • Within the past 5 years, the most significant YoY rise in Elanco Animal Health's Depreciation & Amortization (CF) was 14634.15% (2021), while the steepest drop was 2162.16% (2021).
  • Elanco Animal Health's Depreciation & Amortization (CF) (Quarter) stood at $174.0 million in 2021, then fell by 3.45% to $168.0 million in 2022, then rose by 1.79% to $171.0 million in 2023, then dropped by 4.09% to $164.0 million in 2024, then increased by 7.32% to $176.0 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $176.0 million for Q3 2025, versus $169.0 million for Q2 2025 and $161.0 million for Q1 2025.